Who
John R. Chiminski
Director
Company insider
Files Form 4 as: Director, QuidelOrtho; Director, Bruker Cellular Analysis; Executive Chair, Catalent; Director, Graham Packaging Co.
In numbers
- Trades disclosed
- 167
- Buys
- 1
- Sells
- 19
- Bought
- $93K
- Sold
- $96.1M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 23 Apr 2010
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,532 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —5,547 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —1,109 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,532 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —5,547 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —1,109 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code A | —6,829 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —6,829 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —6,829 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code A | —6,829 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —6,829 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —2,439 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —487 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,523 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code A | —2,523 at $0.00 | filing |
| 2 Oct 2023filed 3 Oct 2023 | Bruker Cellular Analysis | SEC FORM 4 Code D | —71,225 | filing |
| 2 Oct 2023filed 3 Oct 2023 | Bruker Cellular Analysis | SEC FORM 4 Code D | —41,240 | filing |
| 25 May 2023filed 1 Jun 2023 | PhenomeX | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 25 Aug 2022filed 26 Aug 2022 | Catalent | SEC FORM 4 Sold | $4.0M38,934 at $103.04 | filing |
| 24 Aug 2022filed 26 Aug 2022 | Catalent | SEC FORM 4 Code A | —99,275 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.